300 related articles for article (PubMed ID: 32934879)
1. Trial watch : the gut microbiota as a tool to boost the clinical efficacy of anticancer immunotherapy.
Daillère R; Derosa L; Bonvalet M; Segata N; Routy B; Gariboldi M; Budinská E; De Vries IJM; Naccarati AG; Zitvogel V; Caldas C; Engstrand L; Loilbl S; Fieschi J; Heinzerling L; Kroemer G; Zitvogel L
Oncoimmunology; 2020 Jun; 9(1):1774298. PubMed ID: 32934879
[TBL] [Abstract][Full Text] [Related]
2. Elucidating the gut microbiota composition and the bioactivity of immunostimulatory commensals for the optimization of immune checkpoint inhibitors.
Daillère R; Routy B; Goubet AG; Cogdill A; Ferrere G; Alves-Costa Silva C; Fluckiger A; Ly P; Haddad Y; Pizzato E; Thelemaque C; Fidelle M; Mazzenga M; Roberti MP; Melenotte C; Liu P; Terrisse S; Kepp O; Kroemer G; Zitvogel L; Derosa L
Oncoimmunology; 2020 Jul; 9(1):1794423. PubMed ID: 32934888
[TBL] [Abstract][Full Text] [Related]
3. Modulation of Gut Microbiota to Enhance Effect of Checkpoint Inhibitor Immunotherapy.
Wu J; Wang S; Zheng B; Qiu X; Wang H; Chen L
Front Immunol; 2021; 12():669150. PubMed ID: 34267748
[TBL] [Abstract][Full Text] [Related]
4. Effects of gut microbiota on immune responses and immunotherapy in colorectal cancer.
Hou X; Zheng Z; Wei J; Zhao L
Front Immunol; 2022; 13():1030745. PubMed ID: 36426359
[TBL] [Abstract][Full Text] [Related]
5. Modulation of gut microbiota to overcome resistance to immune checkpoint blockade in cancer immunotherapy.
Huang J; Jiang Z; Wang Y; Fan X; Cai J; Yao X; Liu L; Huang J; He J; Xie C; Wu Q; Cao Y; Leung EL
Curr Opin Pharmacol; 2020 Oct; 54():1-10. PubMed ID: 32619934
[TBL] [Abstract][Full Text] [Related]
6. The role of gut microbiota in cancer treatment: friend or foe?
Cheng WY; Wu CY; Yu J
Gut; 2020 Oct; 69(10):1867-1876. PubMed ID: 32759302
[TBL] [Abstract][Full Text] [Related]
7. Modulatory effects of gut microbiome in cancer immunotherapy: A novel paradigm for blockade of immune checkpoint inhibitors.
Rezasoltani S; Yadegar A; Asadzadeh Aghdaei H; Reza Zali M
Cancer Med; 2021 Feb; 10(3):1141-1154. PubMed ID: 33369247
[TBL] [Abstract][Full Text] [Related]
8. Immunogenic cell death: A link between gut microbiota and anticancer effects.
Chen W; Wang S; Wu Y; Shen X; Guo Z; Li Q; Xing D
Microb Pathog; 2020 Apr; 141():103983. PubMed ID: 31954823
[TBL] [Abstract][Full Text] [Related]
9. Fecal microbiota transplantation in cancer management: Current status and perspectives.
Chen D; Wu J; Jin D; Wang B; Cao H
Int J Cancer; 2019 Oct; 145(8):2021-2031. PubMed ID: 30458058
[TBL] [Abstract][Full Text] [Related]
10. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
11. Microbiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa L; Routy B; Desilets A; Daillère R; Terrisse S; Kroemer G; Zitvogel L
Cancer Discov; 2021 Oct; 11(10):2396-2412. PubMed ID: 34400407
[TBL] [Abstract][Full Text] [Related]
12. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Involvement of Gut Microbiota in Cancer Therapy-Induced Cardiotoxicity.
Kunika ; Frey N; Rangrez AY
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108423
[TBL] [Abstract][Full Text] [Related]
14. Exploring the Emerging Role of the Gut Microbiota and Tumor Microenvironment in Cancer Immunotherapy.
Qiu Q; Lin Y; Ma Y; Li X; Liang J; Chen Z; Liu K; Huang Y; Luo H; Huang R; Luo L
Front Immunol; 2020; 11():612202. PubMed ID: 33488618
[TBL] [Abstract][Full Text] [Related]
15. Gut Bacteria Composition Drives Primary Resistance to Cancer Immunotherapy in Renal Cell Carcinoma Patients.
Derosa L; Routy B; Fidelle M; Iebba V; Alla L; Pasolli E; Segata N; Desnoyer A; Pietrantonio F; Ferrere G; Fahrner JE; Le Chatellier E; Pons N; Galleron N; Roume H; Duong CPM; Mondragón L; Iribarren K; Bonvalet M; Terrisse S; Rauber C; Goubet AG; Daillère R; Lemaitre F; Reni A; Casu B; Alou MT; Alves Costa Silva C; Raoult D; Fizazi K; Escudier B; Kroemer G; Albiges L; Zitvogel L
Eur Urol; 2020 Aug; 78(2):195-206. PubMed ID: 32376136
[TBL] [Abstract][Full Text] [Related]
16. Gut microbiota: impacts on gastrointestinal cancer immunotherapy.
Lau HCH; Sung JJ; Yu J
Gut Microbes; 2021; 13(1):1-21. PubMed ID: 33435800
[TBL] [Abstract][Full Text] [Related]
17. Manipulating Gut Microbiota Composition to Enhance the Therapeutic Effect of Cancer Immunotherapy.
Yi M; Jiao D; Qin S; Chu Q; Li A; Wu K
Integr Cancer Ther; 2019; 18():1534735419876351. PubMed ID: 31517538
[TBL] [Abstract][Full Text] [Related]
18. Gut microbiota interactions with antitumor immunity in colorectal cancer: From understanding to application.
Zhuang YP; Zhou HL; Chen HB; Zheng MY; Liang YW; Gu YT; Li WT; Qiu WL; Zhou HG
Biomed Pharmacother; 2023 Sep; 165():115040. PubMed ID: 37364479
[TBL] [Abstract][Full Text] [Related]
19. Gut microbiota: A double-edged sword in immune checkpoint blockade immunotherapy against tumors.
Wang J; Zhu N; Su X; Yang R
Cancer Lett; 2024 Feb; 582():216582. PubMed ID: 38065401
[TBL] [Abstract][Full Text] [Related]
20. The Roles of Inflammation, Nutrient Availability and the Commensal Microbiota in Enteric Pathogen Infection.
Stecher B
Microbiol Spectr; 2015 Jun; 3(3):. PubMed ID: 26185088
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]